S, P., & Y, S. (2026). Variant-specific contributions of CYP21A2 and CYP11B1 to the clinical and hormonal heterogeneity of polyendocrine metabolic ovarian syndrome phenotypes. Molecular biology reports, 53(1), . https://doi.org/10.1007/s11033-026-12498-z
Chicago Style (17th ed.) CitationS, Polat, and Simsek Y. "Variant-specific Contributions of CYP21A2 and CYP11B1 to the Clinical and Hormonal Heterogeneity of Polyendocrine Metabolic Ovarian Syndrome Phenotypes." Molecular Biology Reports 53, no. 1 (2026). https://doi.org/10.1007/s11033-026-12498-z.
MLA (9th ed.) CitationS, Polat, and Simsek Y. "Variant-specific Contributions of CYP21A2 and CYP11B1 to the Clinical and Hormonal Heterogeneity of Polyendocrine Metabolic Ovarian Syndrome Phenotypes." Molecular Biology Reports, vol. 53, no. 1, 2026, https://doi.org/10.1007/s11033-026-12498-z.